Suppr超能文献

CRMarker:癌症 RNA 标志物的人工策管综合资源。

CRMarker: A manually curated comprehensive resource of cancer RNA markers.

机构信息

School of Biological Engineering, Huainan Normal University, Huainan 232001, PR China; Department of Biostatistics and Computational Biology, School of Life Sciences, Fudan University, Shanghai 200436, PR China; Key Laboratory of Industrial Dust Prevention and Control & Occupational Health and Safety, Ministry of Education, Huainan, PR China; Anhui Shanhe Pharmaceutical Excipients Co., Ltd., Huainan, PR China.

School of Biological Engineering, Huainan Normal University, Huainan 232001, PR China.

出版信息

Int J Biol Macromol. 2021 Mar 31;174:263-269. doi: 10.1016/j.ijbiomac.2021.01.186. Epub 2021 Jan 30.

Abstract

Biomolecular markers have extremely important value for cancer research and treatment. However, as far as we know, there are still no searchable and predictable resources focusing on multiple classes of RNA molecular markers in cancers. Herein, we developed CRMarker, a manually curated comprehensive repository of cancer RNA markers. In the current release, CRMarker v1.1 consists of 5489 "known" cancer RNA markers based on 8756 valid publications in PubMed, including 2878 mRNAs (genes), 1314 miRNAs, 1097 lncRNAs and 200 circRNAs, and involving two functional molecules (diagnosis and prognosis), 21 organisms and 154 cancers. The search results provided by the database are comprehensive, including 11 items such as RNA molecule expression and risk level, type of tissue or sample, cancer subtype, reference type, etc. Moreover, CRMarker also provides more than 18,000 potential cancer RNA markers, which are predicted based on "guilt-by-association" analysis of the above-mentioned "known" RNA markers and three molecular interaction networks, and survival analysis of 18 gene expression data sets with survival data. CRMarker v1.1 has a friendly interface and is freely available online at http://crmarker.hnnu.edu.cn/. We aim to build a comprehensive platform that is convenient for cancer researchers and clinicians to inquire and retrieve.

摘要

生物标志物对于癌症的研究和治疗具有极其重要的价值。然而,据我们所知,目前还没有专门针对癌症中多种 RNA 分子标志物的可搜索和可预测的资源。在此,我们开发了 CRMarker,这是一个人工整理的癌症 RNA 标志物综合数据库。在当前版本 CRMarker v1.1 中,包含了 5489 个基于 8756 篇 PubMed 有效文献的“已知”癌症 RNA 标志物,其中包括 2878 个 mRNA(基因)、1314 个 miRNA、1097 个 lncRNA 和 200 个 circRNA,涉及两个功能分子(诊断和预后)、21 个生物体和 154 种癌症。数据库提供的搜索结果全面,包括 RNA 分子表达和风险水平、组织或样本类型、癌症亚型、参考文献类型等 11 个项目。此外,CRMarker 还提供了超过 18000 个潜在的癌症 RNA 标志物,这些标志物是基于对上述“已知”RNA 标志物和三个分子相互作用网络的“关联有罪”分析以及对具有生存数据的 18 个基因表达数据集的生存分析预测得到的。CRMarker v1.1 界面友好,可免费在线访问,网址为:http://crmarker.hnnu.edu.cn/。我们的目标是建立一个方便癌症研究人员和临床医生查询和检索的综合平台。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验